Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data
Contributeurs/tricesCooper, Cyrus; Bardin, Thomas; Brandi, Maria-Luisa; Cacoub, Patrice; Caminis, John; Civitelli, Roberto; Cutolo, Maurizio; Dere, Willard; Devogelaer, Jean-Pierre; Diez-Perez, Adolfo; Einhorn, Thomas A.; Emonts, Patrick; Ethgen, Olivier; Kanis, John A.; Kaufman, Jean-Marc; Kvien, Tore K.; Lems, Willem F.; McCloskey, Eugene; Miossec, Pierre; Reiter, Susanne; Ringe, Johann; Rizzoli, René; Saag, Kenneth; Reginster, Jean-Yves
Publié dansAging Clinical and Experimental Research, vol. 28, no. 1, p. 1-16
Date de publication2016
RemarqueComplément du titre : An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
COOPER, Cyrus et al. Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. In: Aging Clinical and Experimental Research, 2016, vol. 28, n° 1, p. 1–16. doi: 10.1007/s40520-015-0522-1
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:81058
- DOI : 10.1007/s40520-015-0522-1
URL commercialhttp://link.springer.com/10.1007/s40520-015-0522-1
ISSN du journal1594-0667
